DCIS: ductal carcinoma in situ; ER: estrogen receptor; HER2: human epidermal growth factor receptor 2; IHC: immunohistochemistry; LN: lymph node; MRI: magnetic resonance imaging; PR: progesterone receptor. Here, ESR1 is linked to ductal breast carcinoma in situ.